Cargando…

Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy

Booster vaccinations for pertussis are advised in many countries during childhood or adulthood. In a phase IV longitudinal interventional study, we assessed long-term immunity following an extra pertussis booster vaccination in children and adults. Children (9 years of age) were primed in infancy wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Versteegen, Pauline, Bonačić Marinović, Axel A., van Gageldonk, Pieter G. M., van der Lee, Saskia, Hendrikx, Lotte H., Sanders, Elisabeth A. M., Berbers, Guy A. M., Buisman, Anne-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146390/ https://www.ncbi.nlm.nih.gov/pubmed/35632449 http://dx.doi.org/10.3390/vaccines10050693

Ejemplares similares

Robust Humoral and Cellular Immune Responses to Pertussis in Adults After a First Acellular Booster Vaccination
por: van der Lee, Saskia, et al.
Publicado: (2018)

Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles
por: van der Lee, Saskia, et al.
Publicado: (2018)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
por: Knuutila, Aapo, et al.
Publicado: (2022)

Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination
por: Diks, Annieck M., et al.
Publicado: (2022)

Pertussis Circulation Has Increased T-Cell Immunity during Childhood More than a Second Acellular Booster Vaccination in Dutch Children 9 Years of Age
por: Schure, Rose-Minke, et al.
Publicado: (2012)

More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands
por: Versteegen, Pauline, et al.
Publicado: (2021)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Serum IgA Responses against Pertussis Proteins in Infected and Dutch wP or aP Vaccinated Children: An Additional Role in Pertussis Diagnostics
por: Hendrikx, Lotte H., et al.
Publicado: (2011)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy
por: da Silva Antunes, Ricardo, et al.
Publicado: (2021)

Different Long-Term Duration of Seroprotection against Neisseria meningitidis in Adolescents and Middle-Aged Adults after a Single Meningococcal ACWY Conjugate Vaccination in The Netherlands
por: Ohm, Milou, et al.
Publicado: (2020)

Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age?
por: Stoof, Susanne P., et al.
Publicado: (2015)

Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection
por: van der Lee, Saskia, et al.
Publicado: (2017)

Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis
por: van Twillert, Inonge, et al.
Publicado: (2017)

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming
por: Sablerolles, Roos S.G., et al.
Publicado: (2022)

Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants
por: Wijmenga-Monsuur, Alienke J., et al.
Publicado: (2015)

Correction: Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants
por: Wijmenga-Monsuur, Alienke J., et al.
Publicado: (2016)

Antibody responses to Bordetella pertussis and other childhood vaccines in infants born to mothers who received pertussis vaccine in pregnancy – a prospective, observational cohort study from the United Kingdom
por: Rice, T. F., et al.
Publicado: (2019)

Novel Intervention in the Aging Population: A Primary Meningococcal Vaccine Inducing Protective IgM Responses in Middle-Aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2017)

Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2018)

The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam
por: Maertens, Kirsten, et al.
Publicado: (2016)

Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
por: de Greeff, Sabine C., et al.
Publicado: (2010)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
por: Knuutila, Aapo, et al.
Publicado: (2023)

The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections
por: van Twillert, Inonge, et al.
Publicado: (2016)

Seroprevalence of Pertussis in The Gambia: Evidence for Continued Circulation of Bordetella pertussis Despite High Vaccination Rates
por: Scott, Susana, et al.
Publicado: (2015)

BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial
por: Gillard, Joshua, et al.
Publicado: (2022)

Detection of opsonizing antibodies directed against a recently circulating Bordetella pertussis strain in paired plasma samples from symptomatic and recovered pertussis patients
por: Hovingh, Elise S., et al.
Publicado: (2018)

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
por: Yount, Kacy S., et al.
Publicado: (2023)

Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay
por: Lambert, Eleonora E., et al.
Publicado: (2020)

Severe pertussis in a young infant due to household transmission: the needs of pertussis vaccination boosters in Japan
por: Takajo, Daiji, et al.
Publicado: (2018)

Bordetella pertussis Induces Interferon Gamma Production by Natural Killer Cells, Resulting in Chemoattraction by Respiratory Epithelial Cells
por: den Hartog, Gerco, et al.
Publicado: (2020)

Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine
por: van Westen, Els, et al.
Publicado: (2015)

Effectiveness and Timing of Vaccination during School Measles Outbreak
por: Bonačić Marinović, Axel Antonio, et al.
Publicado: (2012)

Underreporting of the 5-year tetanus, diphtheria, pertussis and polio booster vaccination in the Danish Vaccination Register
por: Voss, Sidsel Skou, et al.
Publicado: (2020)

Booster vaccination of pre-school children with reduced-antigen-content diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine co-administered with measles-mumps-rubella-varicella vaccine: A randomized, controlled trial in children primed according to a 2 + 1 schedule in infancy
por: Ferrera, Giuseppe, et al.
Publicado: (2012)

Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
por: Collier, Ai-ris Y., et al.
Publicado: (2023)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
por: Goh, Yun Shan, et al.
Publicado: (2022)

Heterologous booster vaccination with CoronaVac following prime vaccination with mRNA vaccine
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9v1of3f445jmntue3b4ceqcb4l